CanSinoBIO's mRNA COVID-19 vaccine candidate cleared for trials in China
BEIJING: Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday (Apr 4) that its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical...
COVID-19 vaccine maker Moderna flags Japan ambition with sumo sponsorship
TOKYO: Moderna is sponsoring sumo flags in its first such promotion in Japan, as the COVID-19 vaccine maker seeks to wrestle market share from compatriot Pfizer. During that time, 1.63...
Youth with mental health issues can soon get help closer to home under new programme
SINGAPORE - Young people facing mental health issues can soon receive care closer to their homes under a new community-based programme. Such an initiative comes on the back of the...
Moderna booster more effective for those over 60 who took Pfizer jab: NCID
Seven days after taking a booster shot, people above the age of 60 who took Moderna had an average antibody level that was twice as high as those who took...
Japan considers offering fourth COVID-19 vaccine shot: Report
TOKYO: Japan is considering offering a fourth coronavirus vaccine shot later this year, a newspaper reported on Friday (Mar 11), while a government spokesman said a decision would be made...
